Insider · CIK 0001918033

Eydelman Mikhail

Reports to the SEC for 1 company · SAN CARLOS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001918033

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-03-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−2,621 sh	$70.39	−$184K	43,999
2025-03-05	PCVXVaxcyte, Inc.M Exercise/Conversion	SVP, GEN COUNSEL & CORP SEC	MExercise/Conversion	+5,000 sh	$21.41	+$107K	46,620
2025-03-05	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, GEN COUNSEL & CORP SEC	MExercise/Conversion	−5,000 sh	—	—	144,497
2025-03-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−2,267 sh	$71.07	−$161K	41,732
2025-03-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−112 sh	$72.37	−$8,105.44	41,620
2025-03-03	PCVXVaxcyte, Inc.F Tax Payment	SVP, GEN COUNSEL & CORP SEC	FTax Payment	−616 sh	$72.10	−$44.4K	41,620
2025-02-28	PCVXVaxcyte, Inc.F Tax Payment	SVP, GEN COUNSEL & CORP SEC	FTax Payment	−470 sh	$73.02	−$34.3K	42,236
2025-02-27	PCVXVaxcyte, Inc.A Award	SVP, GEN COUNSEL & CORP SEC	AAward	+14.5K sh	—	—	42,706
2025-02-27	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	SVP, GEN COUNSEL & CORP SEC	AAward	+48.4K sh	—	—	48,357
2025-02-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−635 sh	$89.09	−$56.6K	32,016
2025-02-05	PCVXVaxcyte, Inc.M Exercise/Conversion	SVP, GEN COUNSEL & CORP SEC	MExercise/Conversion	+5,000 sh	$21.41	+$107K	33,222
2025-02-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−255 sh	$91.71	−$23.4K	28,222
2025-02-05	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, GEN COUNSEL & CORP SEC	MExercise/Conversion	−5,000 sh	—	—	149,497
2025-02-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−1,755 sh	$89.95	−$158K	30,261
2025-02-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−571 sh	$87.77	−$50.1K	32,651
2025-02-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−1,784 sh	$91.05	−$162K	28,477
2025-01-06	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, GEN COUNSEL & CORP SEC	MExercise/Conversion	−5,000 sh	—	—	154,497
2025-01-06	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−3,921 sh	$85.73	−$336K	28,347
2025-01-06	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−954 sh	$84.86	−$81K	32,268
2025-01-06	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−125 sh	$86.52	−$10.8K	28,222
2025-01-06	PCVXVaxcyte, Inc.M Exercise/Conversion	SVP, GEN COUNSEL & CORP SEC	MExercise/Conversion	+5,000 sh	$21.41	+$107K	33,222
2024-12-09	PCVXVaxcyte, Inc.F Tax Payment	SVP, GEN COUNSEL & CORP SEC	FTax Payment	−475 sh	$92.06	−$43.7K	28,222
2024-12-05	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, GEN COUNSEL & CORP SEC	MExercise/Conversion	−5,000 sh	—	—	159,497
2024-12-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−388 sh	$92.90	−$36K	28,697
2024-12-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−3,177 sh	$91.91	−$292K	29,085
2024-12-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−1,435 sh	$90.16	−$129K	32,262
2024-12-05	PCVXVaxcyte, Inc.M Exercise/Conversion	SVP, GEN COUNSEL & CORP SEC	MExercise/Conversion	+5,000 sh	$21.41	+$107K	33,697
2024-12-05	PCVXVaxcyte, Inc.G Gift	SVP, GEN COUNSEL & CORP SEC	GGift	−110 sh	—	—	28,697
2024-11-07	PCVXVaxcyte, Inc. · Performance Stock Option (right to buy)A Award	SVP, GEN COUNSEL & CORP SEC	AAward	+26.1K sh	—	—	26,125
2024-11-05	PCVXVaxcyte, Inc.M Exercise/Conversion	SVP, GEN COUNSEL & CORP SEC	MExercise/Conversion	+5,000 sh	$21.41	+$107K	33,623
2024-11-05	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, GEN COUNSEL & CORP SEC	MExercise/Conversion	−5,000 sh	—	—	164,497
2024-11-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−1,273 sh	$107.50	−$137K	28,623
2024-11-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−1,524 sh	$106.82	−$163K	29,896
2024-11-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−1,415 sh	$105.72	−$150K	31,420
2024-11-05	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−788 sh	$104.80	−$82.6K	32,835
2024-10-07	PCVXVaxcyte, Inc.M Exercise/Conversion	SVP, GEN COUNSEL & CORP SEC	MExercise/Conversion	+5,000 sh	$21.41	+$107K	33,623
2024-10-07	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, GEN COUNSEL & CORP SEC	MExercise/Conversion	−5,000 sh	—	—	169,497
2024-10-07	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−67 sh	$111.68	−$7,482.56	28,623
2024-10-07	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−314 sh	$110.50	−$34.7K	28,690
2024-10-07	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−3,147 sh	$109.55	−$345K	29,004
2024-10-07	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−996 sh	$108.69	−$108K	32,151
2024-10-07	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−476 sh	$107.51	−$51.2K	33,147
2024-10-01	PCVXVaxcyte, Inc.M Exercise/Conversion	SVP, GEN COUNSEL & CORP SEC	MExercise/Conversion	+5,500 sh	$21.41	+$118K	34,123
2024-10-01	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−1,414 sh	$113.38	−$160K	32,709
2024-10-01	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−3,056 sh	$114.37	−$350K	29,653
2024-10-01	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−1,030 sh	$115.01	−$118K	28,623
2024-10-01	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, GEN COUNSEL & CORP SEC	MExercise/Conversion	−5,500 sh	—	—	174,497
2024-09-03	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−144 sh	$116.01	−$16.7K	30,906
2024-09-03	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−523 sh	$110.45	−$57.8K	31,966
2024-09-03	PCVXVaxcyte, Inc.S Sale	SVP, GEN COUNSEL & CORP SEC	SSale	−79 sh	$114.96	−$9,081.84	31,050

Recent filings

Accepted (ET)
Mar 74
Eydelman Mikhail0001649094-25-000045
SEC(opens sec.gov)
Mar 34
Eydelman Mikhail0001649094-25-000040
SEC(opens sec.gov)
Feb 74
Eydelman Mikhail0001649094-25-000012
SEC(opens sec.gov)
Jan 74
Eydelman Mikhail0001649094-25-000004
SEC(opens sec.gov)

Companies

Vaxcyte, Inc.SVP, GEN COUNSEL & CORP SECPCVX

Address

C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, SUITE 300

SAN CARLOS, CA, 94070